ici 153066 has been researched along with tioconazole in 2 studies
| Studies (ici 153066) | Trials (ici 153066) | Recent Studies (post-2010) (ici 153066) | Studies (tioconazole) | Trials (tioconazole) | Recent Studies (post-2010) (tioconazole) |
|---|---|---|---|---|---|
| 19 | 0 | 0 | 159 | 21 | 46 |
| Protein | Taxonomy | ici 153066 (IC50) | tioconazole (IC50) |
|---|---|---|---|
| Cysteine protease ATG4A | Homo sapiens (human) | 1.3 | |
| Cysteine protease ATG4B | Homo sapiens (human) | 1.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbott, AB; Cockayne, A; Hayward, J; Odds, FC | 1 |
| Cauwenbergh, G | 1 |
2 other study(ies) available for ici 153066 and tioconazole
| Article | Year |
|---|---|
Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Triazoles | 1985 |
New and prospective developments in antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles | 1986 |